As more states are zooming in on the benefits of medical marijuana, another new study recommends the use of the controversial therapy drug for diabetics.
The American Journal of Medicine published a clinical study yesterday on the effect of marijuana on regulating glucose and insulin among adults. Research proponents Elizabeth Penner, Hannah Buettner and Murray Mittleman were able to correlate the impact of marijuana on metabolic processes, specifically on fasting insulin, glucose, and insulin resistance, according to Medical Daily.
Based on the study conducted, it was found that use of medical marijuana was beneficial in decreasing the amount of fasting insulin and the chances of insulin resistance. Current marijuana users were able to receive such benefits, while the effect was weaker on those who were not taking marijuana anymore. Meanwhile, fasting insulin levels were lower by 16 percent in people who have never tried taking marijuana. In addition, people who regularly take marijuana had significantly smaller waistlines.
The study involved pre-selected adults from the database of the National Health and Nutrition Examination Survey between 2005 and 2010. About 12 percent of the respondents are current marijuana users, while close to half of the whole study group has never used marijuana.
Joseph Alpert, editor-in-chief of the American Journal of Medicine, supported the breakthrough study. He said that the results of the study were remarkable and are backed up by scientific fundamentals. He further recommends that a similar study be conducted for other clinical cases such as cancer and elderly health.